2020
DOI: 10.1016/j.bbagen.2020.129602
|View full text |Cite
|
Sign up to set email alerts
|

HIF1α/PLD2 axis linked to glycolysis induces T-cell immunity in oral lichen planus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 32 publications
0
10
0
Order By: Relevance
“…Wang et al (34) reported that the PLD2/MTOR/HIF-1α signal might play an important role in immune dysfunction in OLP patients. It has also been reported that PLD2 is highly expressed in OLP, and PLD2 promotes T-cell proliferation and pro-inflammatory phenotype differentiation in OLP (35). Additionally, 6 immune-related signal pathways were enriched, which suggests that abnormally expressed circRNAs may be involved in regulating the immune process.…”
Section: Discussionmentioning
confidence: 83%
“…Wang et al (34) reported that the PLD2/MTOR/HIF-1α signal might play an important role in immune dysfunction in OLP patients. It has also been reported that PLD2 is highly expressed in OLP, and PLD2 promotes T-cell proliferation and pro-inflammatory phenotype differentiation in OLP (35). Additionally, 6 immune-related signal pathways were enriched, which suggests that abnormally expressed circRNAs may be involved in regulating the immune process.…”
Section: Discussionmentioning
confidence: 83%
“…25 Our previous findings revealed that the activation of mTOR pathway in T cells varied with glucose concentration, demonstrating mTOR serves as an important metabolic sensor. 9 Besides, inhibition of mTOR pathway could reduce the expression of Hif1α in T cells, 14 which is a major transcriptional regulator of LDHA. Either downregulation of mTOR or Hif1α could lead to the inhibition of LDHA.…”
Section: -Dg Is Considered As An Inhibitor Of Glucose Metabolismmentioning
confidence: 99%
“…Moreover, molecular pathways, including mammalian target of rapamycin (mTOR), hypoxia‐inducible factor 1α (HIF1α) and phospholipase D2 (PLD2), motivate glycolytic metabolism in T cells 11–13 . We have found that the expression of p‐mTOR, HIF1α and PLD2 was elevated in peripheral or local T cells of OLP, and mTOR/HIF1α/PLD2 axis could upregulate the phosphorylation of LDHA in T cells 9,14,15 . Besides, mTOR pathway could dynamically respond to extracellular glucose signals, then correspondingly regulate T‐cell glycolysis, and finally support T‐cell proliferation and differentiation 9 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Wang et al confirmed that the mTOR pathway played a vital role in the immunometabolism of T lymphocytes in OLP patients 9 . The HIF1α/PLD2 axis was enriched in OLP lesions, which was thought to be a key regulatory signaling pathway involving T-lymphocyte immunity by promoting T-lymphocyte proliferation and pro-inflammatory phenotype differentiation of OLP 10 , 11 . Various inflammation-related cytokines from OLP patients, including interleukins (ILs) 12 , 13 , transforming growth factor-β (TGF-β) 14 , interferon-γ (IFN-γ) 15 and tumor necrosis factor-α (TNF-α) 16 , have been shown to play an important role in immune disorders.…”
Section: Introductionmentioning
confidence: 99%